Lynlee Muehring joined COUR in 2023 as VP, Clinical Development Operations where she oversees the strategy for implementation and the execution of all clinical trials.
Lynlee’s career in clinical operations and program management spans over two decades, marked by her recent role as Senior Director of Clinical Trials Management at Jaguar Gene Therapy from 2020. Prior to this, she served as Senior Director of Clinical Operations at Abeona Therapeutics from 2019 to 2020. Her journey began in clinical operations with roles that steadily evolved into leadership positions, including Associate Director and Program Lead at AveXis, Manager and Clinical Project Leader at Sanofi, Clinical Operations Lead at Novo Nordisk, and Clinical Team Leader at INC Research. Lynlee’s early career as a Clinical Research Associate included senior roles at organizations like Actelion, Merk, PPD, Quintiles Translational, and Kendle International.
Lynlee graduated from Kansas State University with a Bachelors in Mathematics, Microbiology, and a Minor in Chemistry.